Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Dendreon: The Big Push on Provenge Begins
Seeking Alpha
Tue, 02/22/11 - 12:54 pm
Tags:
Provenge, Dendreon, vaccines, prostate cancer
Why The New Dendreon Analysis Does Matter — And Why It Doesn’t
Forbes
Sat, 02/19/11 - 11:39 am
Tags:
Provenge, prostate cancer, Dendreon
Dendreon Adds Ammo to Provenge Defense
Minyanville
Sat, 02/19/11 - 11:13 am
Tags:
Dendreon, Provenge
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
Tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
Investors scour biotechs in search of the next big payoff
Fierce Biotech
Fri, 02/18/11 - 09:40 am
Tags:
investors, biotech, Dendreon, Human Genome Sciences, Biomarin, Alexion
Good News for Dendreon's Provenge
Seeking Alpha
Fri, 02/18/11 - 09:33 am
Tags:
Provenge, prostate cancer, Dendreon, vaccines
Dendreon, Teva: Benefit by Riding George Soros's Coattails
Seeking Alpha
Tue, 02/15/11 - 10:24 am
Tags:
Teva Pharmaceuticals, Dendreon, George Soros
Zibotentan Stopped, Long Live Provenge (for Now)
Motley Fool
Mon, 02/7/11 - 07:27 pm
Tags:
Provenge, Dendreon, zibotentan, prostate cancer, AstraZeneca
Pfizer's Newest Acquisition Target
Motley Fool
Thu, 02/3/11 - 10:33 am
Tags:
Pfizer, M&A, Clinical Data, Dendreon, Amarin
Dendreon expects $529.2M from senior note sale
Yahoo/AP
Sat, 01/15/11 - 12:21 pm
Tags:
Dendreon
Dendreon offering $500 million in notes
Yahoo/AP
Fri, 01/14/11 - 09:51 am
Tags:
Dendreon
9 Biotech Stocks for 2011
Seeking Alpha
Fri, 01/14/11 - 09:50 am
Tags:
Cepheid, Cerus, Curis, Illumina, Questcor Pharmaceuticals, CompuGen, Spectrum Pharmaceuticals, Impax, Human Genome Sciences, Vertex Pharmaceuticals, Orexigen, Dendreon
Dendreon Reports Provenge Sales, Plans for Expansion
Bloomberg
Sat, 01/8/11 - 11:50 am
Tags:
Dendreon, Provenge, prostate cancer
Dendreon Bringing Provenge to Europe
TheStreet.com
Fri, 01/7/11 - 09:57 am
Tags:
Provenge, Europe, Dendreon, vaccines, prostate cancer
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Tags:
Oncothyreon, Xoma, Amarin, Opexa, Human Genome, Seattle Genetics, Vertex Pharmaceuticals, Merck, Dendreon, Biogen Idec, Amgen, Pharmasset
Yet Another Group Sues Medicare Over Provenge
Pharmalot
Thu, 01/6/11 - 01:16 pm
Tags:
Medicare, Provenge, Dendreon, prostate cancer
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
Tags:
biotech, Celgene, Dendreon, MannKind, Vertex Pharmaceuticals, Genzyme, Ariad Pharmaceuticals, Keryx
Takeovers Vs. R&D: What Will Drive Biotech Stocks in 2011?
Seeking Alpha
Tue, 12/28/10 - 02:08 pm
Tags:
R&D, biotech, M&A, Cepheid, Abbott Laboratories, Bristol-Myers Squibb, Dendreon, Elan, Biogen Idec, JNJ, King, Neurocrine, Pfizer, SPDR Biotech
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Tags:
Athenahealth, Abbott Laboratories, Beckman Coulter, Agilent, AstraZeneca, Provenge, Dendreon, Benlysta, Human Genome Sciences, Telaprevir, Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
Tags:
MannKind, Afrezza, Alimera, pSivida, Seattle Genetics, brentuximab vedotin, Illuvien, AstraZeneca, Zictifa, Clinical Data, Vilazodone, Orexigen, Contrave, Bristol-Myers Squibb, Yervoy, Pfizer, Protalix BioTherapeutics, UPLYSO, Xiafaxan, Salix, Human Genome Sciences, Benlysta, Dendreon, Provenge, InterMune, Esbriet, Cell Therapeutics, pixantrone, Forest Labs, Daxas, MELA Sciences, MelaFind, XenoPort, GSK, Horizant, Spectrum Pharmaceuticals, Fusilev, Adventrx, Vertex Pharmaceuticals, Telaprevir

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.